City Of Saint Peters, MONCT04557956Now EnrollingIRB Ready

Metastatic Melanoma Clinical Trial in City Of Saint Peters, MO

Access cutting-edge metastatic melanoma treatment through this clinical trial at a research site in City Of Saint Peters. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this City Of Saint Peters location

Preparing your pre-screening questions...

Expert Care in City Of Saint Peters

Access metastatic melanoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related metastatic melanoma treatment provided free

Apply for This City Of Saint Peters Location

Check if you qualify for this metastatic melanoma clinical trial in City Of Saint Peters, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to City Of Saint Peters

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit City Of Saint Peters site if eligible
  4. 4Begin participation

About This Metastatic Melanoma Study in City Of Saint Peters

This phase I/II trial investigates the best dose, possible benefits and/or side effects of tazemetostat in combination with dabrafenib and trametinib in treating patients with melanoma that has a specific mutation in the BRAF gene (BRAFV600) and that has spread from where it first started (primary site) to other places in the body (metastatic). Tazemetostat, dabrafenib, and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving tazemetostat i

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

Patient must have a diagnosis of BRAF\^V600E/K-mutated metastatic melanoma
Patient must have had documented radiographic or clinical evidence of progressive disease while on combination BRAF/MEK inhibitor therapy. For Phase 2 only, no more than one intervening therapy since progression on BRAF/MEK inhibitor therapy is allowed. Subjects who have evidence of progression while on, or within 4 weeks of completing, combination BRAF/MEK inhibitor therapy in the adjuvant setting will be eligible
PHASE 2 ONLY: Patient must have EZH2 alteration (somatic mutation or copy number alteration). Can be performed on either archival or fresh specimen. EZH2 alterations need to be documented by a Clinical Laboratory Improvement Act (CLIA)/Clinical Laboratory Improvement Program (CLIP)-certified next generation sequencing platform (Foundation One, Tempus, Guardant360, etc.)
PHASE 2 ONLY: Patient must have measurable disease
PHASE 2 ONLY: Patient must have at least one tumor

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in City Of Saint Peters?

Yes, this clinical trial (NCT04557956) has an active research site in City Of Saint Peters, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Metastatic Melanoma Treatment Options in City Of Saint Peters, MO

If you're searching for metastatic melanoma treatment options in City Of Saint Peters, MO, this clinical trial (NCT04557956) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our City Of Saint Peters research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all metastatic melanoma clinical trials near you to find additional studies recruiting in your area.

More Melanoma Trials in City Of Saint Peters, MO

See all melanoma clinical trials recruiting in City Of Saint Peters — not just this study.

Browse Melanoma Trials in City Of Saint Peters →

Browse More Trials by Condition

Melanoma TrialsEssential Tremor TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in City Of Saint Peters?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · City Of Saint Peters, MO